King Pharma: Actavis Has Made FDA Filing

King Pharmaceuticals Inc. said Monday that it’s learned that Icelandic generic drug maker Actavis has filed a Paragraph IV Certification with the U.S. Food & Drug Administration pertaining to King’s Avinza product.
Market Watch